SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending as shareholders shift their focus toward Greg Abel's leadership transition and the company's record cash stockpile. Community members are actively debating the conglomerate's future strategy, particularly whether its massive liquidity will be used for large-scale acquisitions or further share repurchases under the new executive team.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals is capturing market attention as investors weigh its robust cystic fibrosis franchise against the strategic potential of its expanding pipeline in gene editing, pain management, and autoimmune kidney diseases. The community is actively discussing recent M&A activity and collaboration deals, with many bullishly monitoring the company's ability to leverage its significant cash flow to de-risk and scale innovative therapies.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased community chatter as traders debate its long-term viability, with many pointing to its post-quantum cryptography features and enterprise-grade infrastructure as key differentiators. While some holders emphasize the potential for a breakthrough and accumulation at current levels, others remain skeptical about the token's price performance and ongoing project developments.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devon Energy is currently a focal point for investors as it integrates its massive merger with Coterra Energy while navigating a volatile energy market driven by geopolitical instability in the Middle East. The community is actively debating the potential for increased shareholder returns, including share buybacks and dividend growth, as the firm works to streamline operations and capitalize on its strengthened position in the Permian Basin.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors bet on its upcoming merger with Agility Robotics, a pure-play humanoid robotics firm backed by major strategic players like Amazon and NVIDIA. Community discussion is focused on the stock's potential for significant upside as it moves toward commercialization, with many drawing parallels to successful past SPAC stories and emphasizing the massive growth potential of the physical AI and robotics sector.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is seeing intense investor interest following a series of strategic hires and ongoing U.S. government validation, with community discussions heavily focused on the company's potential to solve critical scaling bottlenecks in AI infrastructure. Investors are actively debating the timing of commercial milestones, while many point to the elevated short interest as a primary catalyst for potential volatility and future upside.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is currently facing intense bearish sentiment and significant downward price pressure as investors debate whether recent network upgrades like Polkadot 2.0 and supply caps can revive long-term utility. While some community members are aggressively accumulating at these lows and citing technical developments, others are heavily shorting the asset, leading to ongoing speculation about a potential short squeeze against a backdrop of wider market uncertainty.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing significant selling pressure, with community sentiment deeply polarized between investors viewing the low price as a prime accumulation opportunity and those frustrated by the token's prolonged underperformance compared to other major crypto assets. Discussions are heavily focused on the disconnect between the network's ongoing real-world adoption and the technical weakness in its price action, leaving traders debating whether this is a long-term value play or a failed project.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is trending due to the announcement of a new NASA contract for a private astronaut mission to the ISS, which the community sees as a major validation of the company's long-term commercial space strategy. Investors are actively debating the stock's future, balancing optimism around its role in upcoming lunar infrastructure and defense-related space initiatives against frustrations with recent price volatility.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is in the spotlight as investors await a critical FDA Advisory Committee meeting and subsequent decision, with market sentiment split between concerns over the company's cash runway and skepticism regarding the clinical data for RP1. Community discussion is heavily focused on the high short interest and binary outcome risks, as traders debate whether the FDA will follow previous rejections or grant an accelerated approval based on unmet medical needs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
